Frontiers in Surgery (Oct 2015)

Rectopexy for Rectal Prolapse

  • Nasra N Alam,
  • Sunil K Narang,
  • Ferdinand eKöckerling,
  • Ian R Daniels,
  • Neil J Smart

DOI
https://doi.org/10.3389/fsurg.2015.00054
Journal volume & issue
Vol. 2

Abstract

Read online

IntroductionVentral mesh rectopexy (VMR) is a recognised treatment for posterior compartment pelvic organ prolapse (POP). The aim of this review is to provide a synopsis of the evidence for biologic mesh use in VMR, the most widely recognised surgical technique for posterior compartment POP.MethodsA systematic search of PubMed was conducted using the search terms ‘VMR’, ‘ventral mesh rectopexy’ or ‘mesh rectopexy’. Six studies were identified.Results268/324 patients underwent ventral rectopexy using biological mesh with a further 6 patients having a combination of synthetic and biological mesh. Recurrence was reported in 20 patients; however, 6 were from studies where data on biological mesh could not be extracted. There are no RCTs in VMR surgery and no studies have directly compared types of biologic mesh. Cross-linked porcine dermal collagen is the most commonly used mesh and has not been associated with mesh erosion, infection or fistulation in this review. The level of evidence available on the use of biologic mesh in VMR is of low quality (level 4).ConclusionsVMR has become prevalent for posterior compartment POP. The evidence base for its implementation is not strong and the quality of evidence to inform choice of mesh is poor.

Keywords